Self-Determination Theory and Motivational Interviewing

Schizophrenia Clinical Trial

Official title:

Developing and Testing of Integrating Self-Determination Theory and Motivational Interviewing Based Diabetic Self-management Program Among Schizophrenic Patients With Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04611737
• Other study ID #: KMUHIRB-SV(I)-20200019
• Status: Completed
• Phase: N/A
• Start date: November 3, 2020
• Est. completion date: May 24, 2023

Study information

• Verified date: October 2020
• Source: Kaohsiung Medical University Chung-Ho Memorial Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Self-Determination Theory and motivational interviewing would be integrated to enhance the efficacy of diabetic self-management for patients with schizophrenia and Type 2 Diabetes.

Description:

Participants would be randomly allocated into either the intervention group or the usual care group from baseline to 3 months follow-up. The intervention is based on integrated self-determination theory and motivational interviewing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: May 24, 2023
• Est. primary completion date: May 24, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• patients with schizophrenia and Type 2 Diabetes
• between 20 years old to 80 years old
• can communicate in Chinese langue

Exclusion Criteria:

• can not communicate well
• have neurocognitive disorders

Related Conditions & MeSH terms

• Diabetes
• Schizophrenia

Intervention

Behavioral:
• Interviewing
Self-Determination Theory within motivational interviewing

Locations

Country	Name	City	State
Taiwan	Kaohsiung Medical University Hospital	Kaohsiung

Sponsors (1)

Lead Sponsor	Collaborator
Kaohsiung Medical University Chung-Ho Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HbA1C	Blood sugar level during the 3 months	on interviewing day1, and 3 months
Primary	Body weight	weight (in kilograms)	on interviewing day1, and 3 months
Primary	height	height (in meters), eight and height will be combined to report BMI in kg/m^2	on interviewing day1, and 3 months
Secondary	Brief Psychiatric Rating Scale	The Brief Psychiatric Rating Scale with 18 items is use to measure psychiatric symptoms. Each symptom is rated 1-7 with higher scores indicating severer symptoms.	on interviewing day1, and 3 months
Secondary	Treatment Self-Regulation Questionnaire-Diabetes	The treatment Self-Regulation Questionnaire-Diabetes a 19-item scale used to examine the self-regulation behaviors for diabetes of participants. Each item is ranged from 1 to 7 and higher scores showing more motivations in self-regulation diabetes.	on interviewing day1, and 3 months
Secondary	Perceived Diabetes Self-Management Scale	The Perceived Diabetes Self-Management Scale is an 8-item scale with 4 of the items (1, 2, 6, & 7) being reverse-scored. Each item is ranged from 1 to 5 and higher scores showing more confidence in self-managing diabetes.	on interviewing day1, and 3 months
Secondary	Depression Anxiety Stress Scales	The Depression Anxiety Stress Scales is a self-report scale with 21 items designed to assess depression, stress and anxiety of participants. Scores for each symptom is ranged from 0 to 3 with higher scores indicating severer symptoms.	on interviewing day1, and 3 months